PCN103 Cost-Effectiveness Analysis of Trastuzumab Emtansine for Adjuvant Treatment of Adult Patients with HER2+ EARLY Breast Cancer in Turkey
Autor: | L. Yanik, E. Erdogan-Ciftci, B. Akyol Ersoy, G. Ozcan, B. Guler |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty Adult patients business.industry Health Policy medicine.medical_treatment Public Health Environmental and Occupational Health Cost-effectiveness analysis chemistry.chemical_compound chemistry Trastuzumab emtansine Internal medicine medicine business Adjuvant Early breast cancer |
Zdroj: | Value in Health. 23:S441 |
ISSN: | 1098-3015 |
DOI: | 10.1016/j.jval.2020.08.240 |
Databáze: | OpenAIRE |
Externí odkaz: |